Mizuho cuts Corbus Pharmaceuticals target price to $24 from $33
CRBP•Mizuho cut its target price for Corbus Pharmaceuticals Holdings to $24 from $33.
Related News
ADC Therapeutics' Zynlonta shows 58.1% response rate in Japanese lymphoma study
ADCT•
Street view: Oracle's funding and AI growth concerns ease after analyst day
ORCL•
DoorDash Q3 revenue tops estimates on order growth; to acquire Instacart
CART•
LKQ publishes third-quarter 2026 earnings presentation
LKQ•
How could the oil spill off the UAE coast affect desalination plants?
XYL•